APO Research
Talk to an analyst

APO RESEARCH · REPORT

Crigler-Najjar Syndrome Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Crigler-Najjar Syndrome Drug Industry Growth and Trends Forecast to 2032

26 December 202575 pages

Choose your research edition.

Industry ResearchCrigler-Najjar Syndrome Drug Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Crigler-Najjar Syndrome Drug Industry Growth and Trends Forecast to 203275 pages · $3,450 USDMarket StructureGlobal Crigler-Najjar Syndrome Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032173 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Crigler-Najjar Syndrome Drug Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Crigler-Najjar Syndrome Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Crigler-Najjar Syndrome Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Crigler-Najjar Syndrome Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Crigler-Najjar Syndrome Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Crigler-Najjar Syndrome Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Crigler-Najjar Syndrome Drug include Audentes Therapeutics Inc, Genethon SA, International Stem Cell Corp and Promethera Biosciences SA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Crigler-Najjar Syndrome Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Crigler-Najjar Syndrome Drug market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Crigler-Najjar Syndrome Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Crigler-Najjar Syndrome Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Crigler-Najjar Syndrome Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Crigler-Najjar Syndrome Drug Market by Company

Audentes Therapeutics Inc

Genethon SA

International Stem Cell Corp

Promethera Biosciences SA

Crigler-Najjar Syndrome Drug Segment by Type

ALXN-1540

AT-342

HepaStem

Others

Crigler-Najjar Syndrome Drug Segment by Application

Hospital

Clinic

Others

Crigler-Najjar Syndrome Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Crigler-Najjar Syndrome Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Crigler-Najjar Syndrome Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Crigler-Najjar Syndrome Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Crigler-Najjar Syndrome Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Crigler-Najjar Syndrome Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of ALXN-1540 Table 2. Major Company of AT-342 Table 3. Major Company of HepaStem Table 4. Major Company of Others Table 5. Global Crigler-Najjar Syndrome Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Crigler-Najjar Syndrome Drug Sales by Type (2021-2026) & (W Units) Table 7. Global Crigler-Najjar Syndrome Drug Sales Market Share in Volume by Type (2021-2026) Table 8. Global Crigler-Najjar Syndrome Drug Sales by Type (2021-2026) & (US$ Million) Table 9. Global Crigler-Najjar Syndrome Drug Sales Market Share in Value by Type (2021-2026) Table 10. Global Crigler-Najjar Syndrome Drug Price by Type (2021-2026) & (US$/Unit) Table 11. Global Crigler-Najjar Syndrome Drug Sales by Type (2027-2032) & (W Units) Table 12. Global Crigler-Najjar Syndrome Drug Sales Market Share in Volume by Type (2027-2032) Table 13. Global Crigler-Najjar Syndrome Drug Sales by Type (2027-2032) & (US$ Million) Table 14. Global Crigler-Najjar Syndrome Drug Sales Market Share in Value by Type (2027-2032) Table 15. Global Crigler-Najjar Syndrome Drug Price by Type (2027-2032) & (US$/Unit) Table 16. North America Crigler-Najjar Syndrome Drug Sales by Type (2021-2026) & (W Units) Table 17. North America Crigler-Najjar Syndrome Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Crigler-Najjar Syndrome Drug Sales by Type (2021-2026) & (W Units) Table 19. Europe Crigler-Najjar Syndrome Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Crigler-Najjar Syndrome Drug Sales by Type (2021-2026) & (W Units) Table 21. Asia-Pacific Crigler-Najjar Syndrome Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Crigler-Najjar Syndrome Drug Sales by Type (2021-2026) & (W Units) Table 23. Latin America Crigler-Najjar Syndrome Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Crigler-Najjar Syndrome Drug Sales by Type (2021-2026) & (W Units) Table 25. Middle East and Africa Crigler-Najjar Syndrome Drug Sales by Type (2021-2026) & (US$ Million) Table 26. Crigler-Najjar Syndrome Drug Industry Trends Table 27. Crigler-Najjar Syndrome Drug Industry Drivers Table 28. Crigler-Najjar Syndrome Drug Industry Opportunities and Challenges Table 29. Crigler-Najjar Syndrome Drug Industry Restraints Table 30. Global Crigler-Najjar Syndrome Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Crigler-Najjar Syndrome Drug Revenue Market Share by Company (2021-2026) Table 32. Global Crigler-Najjar Syndrome Drug Sales by Company (2021-2026) & (W Units) Table 33. Global Crigler-Najjar Syndrome Drug Sales Share by Company (2021-2026) Table 34. Global Crigler-Najjar Syndrome Drug Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Crigler-Najjar Syndrome Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Crigler-Najjar Syndrome Drug Major Company Production Sites and Headquarters Table 37. Global Crigler-Najjar Syndrome Drug Company, Product Type & Application Table 38. Global Crigler-Najjar Syndrome Drug Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Crigler-Najjar Syndrome Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Crigler-Najjar Syndrome Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Crigler-Najjar Syndrome Drug Sales by Region (2021-2026) & (W Units) Table 43. Global Crigler-Najjar Syndrome Drug Sales Market Share in Volume by Region (2021-2026) Table 44. Global Crigler-Najjar Syndrome Drug Sales by Region (2021-2026) & (US$ Million) Table 45. Global Crigler-Najjar Syndrome Drug Sales Market Share in Value by Region (2021-2026) Table 46. Global Crigler-Najjar Syndrome Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Crigler-Najjar Syndrome Drug Sales by Region (2027-2032) & (W Units) Table 48. Global Crigler-Najjar Syndrome Drug Sales Market Share in Volume by Region (2027-2032) Table 49. Global Crigler-Najjar Syndrome Drug Sales by Region (2027-2032) & (US$ Million) Table 50. Global Crigler-Najjar Syndrome Drug Sales Market Share in Value by Region (2027-2032) Table 51. Global Crigler-Najjar Syndrome Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Crigler-Najjar Syndrome Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Crigler-Najjar Syndrome Drug Sales by Application (2021-2026) & (W Units) Table 54. Global Crigler-Najjar Syndrome Drug Sales Market Share in Volume by Application (2021-2026) Table 55. Global Crigler-Najjar Syndrome Drug Sales by Application (2021-2026) & (US$ Million) Table 56. Global Crigler-Najjar Syndrome Drug Sales Market Share in Value by Application (2021-2026) Table 57. Global Crigler-Najjar Syndrome Drug Price by Application (2021-2026) & (US$/Unit) Table 58. Global Crigler-Najjar Syndrome Drug Sales by Application (2027-2032) & (W Units) Table 59. Global Crigler-Najjar Syndrome Drug Sales Market Share in Volume by Application (2027-2032) Table 60. Global Crigler-Najjar Syndrome Drug Sales by Application (2027-2032) & (US$ Million) Table 61. Global Crigler-Najjar Syndrome Drug Sales Market Share in Value by Application (2027-2032) Table 62. Global Crigler-Najjar Syndrome Drug Price by Application (2027-2032) & (US$/Unit) Table 63. North America Crigler-Najjar Syndrome Drug Sales by Application (2021-2026) & (W Units) Table 64. North America Crigler-Najjar Syndrome Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Crigler-Najjar Syndrome Drug Sales by Application (2021-2026) & (W Units) Table 66. Europe Crigler-Najjar Syndrome Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Crigler-Najjar Syndrome Drug Sales by Application (2021-2026) & (W Units) Table 68. Asia-Pacific Crigler-Najjar Syndrome Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Crigler-Najjar Syndrome Drug Sales by Application (2021-2026) & (W Units) Table 70. Latin America Crigler-Najjar Syndrome Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Crigler-Najjar Syndrome Drug Sales by Application (2021-2026) & (W Units) Table 72. Middle East and Africa Crigler-Najjar Syndrome Drug Sales by Application (2021-2026) & (US$ Million) Table 73. Audentes Therapeutics Inc Company Information Table 74. Audentes Therapeutics Inc Business Overview Table 75. Audentes Therapeutics Inc Crigler-Najjar Syndrome Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Audentes Therapeutics Inc Crigler-Najjar Syndrome Drug Product Portfolio Table 77. Audentes Therapeutics Inc Recent Development Table 78. Genethon SA Company Information Table 79. Genethon SA Business Overview Table 80. Genethon SA Crigler-Najjar Syndrome Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Genethon SA Crigler-Najjar Syndrome Drug Product Portfolio Table 82. Genethon SA Recent Development Table 83. International Stem Cell Corp Company Information Table 84. International Stem Cell Corp Business Overview Table 85. International Stem Cell Corp Crigler-Najjar Syndrome Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. International Stem Cell Corp Crigler-Najjar Syndrome Drug Product Portfolio Table 87. International Stem Cell Corp Recent Development Table 88. Promethera Biosciences SA Company Information Table 89. Promethera Biosciences SA Business Overview Table 90. Promethera Biosciences SA Crigler-Najjar Syndrome Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Promethera Biosciences SA Crigler-Najjar Syndrome Drug Product Portfolio Table 92. Promethera Biosciences SA Recent Development Table 93. North America Crigler-Najjar Syndrome Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 94. North America Crigler-Najjar Syndrome Drug Sales by Country (2021-2026) & (W Units) Table 95. North America Crigler-Najjar Syndrome Drug Sales Market Share by Country (2021-2026) Table 96. North America Crigler-Najjar Syndrome Drug Sales Forecast by Country (2027-2032) & (W Units) Table 97. North America Crigler-Najjar Syndrome Drug Sales Market Share Forecast by Country (2027-2032) Table 98. North America Crigler-Najjar Syndrome Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. North America Crigler-Najjar Syndrome Drug Market Size by Country (2021-2026) & (US$ Million) Table 100. North America Crigler-Najjar Syndrome Drug Market Share by Country (2021-2026) Table 101. North America Crigler-Najjar Syndrome Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. North America Crigler-Najjar Syndrome Drug Market Share Forecast by Country (2027-2032) Table 103. Europe Crigler-Najjar Syndrome Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 104. Europe Crigler-Najjar Syndrome Drug Sales by Country (2021-2026) & (W Units) Table 105. Europe Crigler-Najjar Syndrome Drug Sales Market Share by Country (2021-2026) Table 106. Europe Crigler-Najjar Syndrome Drug Sales Forecast by Country (2027-2032) & (W Units) Table 107. Europe Crigler-Najjar Syndrome Drug Sales Market Share Forecast by Country (2027-2032) Table 108. Europe Crigler-Najjar Syndrome Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Europe Crigler-Najjar Syndrome Drug Market Size by Country (2021-2026) & (US$ Million) Table 110. Europe Crigler-Najjar Syndrome Drug Market Share by Country (2021-2026) Table 111. Europe Crigler-Najjar Syndrome Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Europe Crigler-Najjar Syndrome Drug Market Share Forecast by Country (2027-2032) Table 113. Asia-Pacific Crigler-Najjar Syndrome Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 114. Asia-Pacific Crigler-Najjar Syndrome Drug Sales by Country (2021-2026) & (W Units) Table 115. Asia-Pacific Crigler-Najjar Syndrome Drug Sales Market Share by Country (2021-2026) Table 116. Asia-Pacific Crigler-Najjar Syndrome Drug Sales Forecast by Country (2027-2032) & (W Units) Table 117. Asia-Pacific Crigler-Najjar Syndrome Drug Sales Market Share Forecast by Country (2027-2032) Table 118. Asia-Pacific Crigler-Najjar Syndrome Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Asia-Pacific Crigler-Najjar Syndrome Drug Market Size by Country (2021-2026) & (US$ Million) Table 120. Asia-Pacific Crigler-Najjar Syndrome Drug Market Share by Country (2021-2026) Table 121. Asia-Pacific Crigler-Najjar Syndrome Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Asia-Pacific Crigler-Najjar Syndrome Drug Market Share Forecast by Country (2027-2032) Table 123. Latin America Crigler-Najjar Syndrome Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 124. Latin America Crigler-Najjar Syndrome Drug Sales by Country (2021-2026) & (W Units) Table 125. Latin America Crigler-Najjar Syndrome Drug Sales Market Share by Country (2021-2026) Table 126. Latin America Crigler-Najjar Syndrome Drug Sales Forecast by Country (2027-2032) & (W Units) Table 127. Latin America Crigler-Najjar Syndrome Drug Sales Market Share Forecast by Country (2027-2032) Table 128. Latin America Crigler-Najjar Syndrome Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Latin America Crigler-Najjar Syndrome Drug Market Size by Country (2021-2026) & (US$ Million) Table 130. Latin America Crigler-Najjar Syndrome Drug Market Share by Country (2021-2026) Table 131. Latin America Crigler-Najjar Syndrome Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Latin America Crigler-Najjar Syndrome Drug Market Share Forecast by Country (2027-2032) Table 133. Middle East and Africa Crigler-Najjar Syndrome Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 134. Middle East and Africa Crigler-Najjar Syndrome Drug Sales by Country (2021-2026) & (W Units) Table 135. Middle East and Africa Crigler-Najjar Syndrome Drug Sales Market Share by Country (2021-2026) Table 136. Middle East and Africa Crigler-Najjar Syndrome Drug Sales Forecast by Country (2027-2032) & (W Units) Table 137. Middle East and Africa Crigler-Najjar Syndrome Drug Sales Market Share Forecast by Country (2027-2032) Table 138. Middle East and Africa Crigler-Najjar Syndrome Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Middle East and Africa Crigler-Najjar Syndrome Drug Market Size by Country (2021-2026) & (US$ Million) Table 140. Middle East and Africa Crigler-Najjar Syndrome Drug Market Share by Country (2021-2026) Table 141. Middle East and Africa Crigler-Najjar Syndrome Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Middle East and Africa Crigler-Najjar Syndrome Drug Market Share Forecast by Country (2027-2032) Table 143. Key Raw Materials Table 144. Raw Materials Key Suppliers Table 145. Crigler-Najjar Syndrome Drug Distributors List Table 146. Crigler-Najjar Syndrome Drug Customers List Table 147. Research Programs/Design for This Report Table 148. Authors List of This Report Table 149. Secondary Sources Table 150. Primary Sources List of Figures Figure 1. Crigler-Najjar Syndrome Drug Image Figure 2. Global Crigler-Najjar Syndrome Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Crigler-Najjar Syndrome Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Crigler-Najjar Syndrome Drug Sales (2021-2032) & (W Units) Figure 5. ALXN-1540 Image Figure 6. Global ALXN-1540 Sales YoY Growth (2021-2032) & (W Units) Figure 7. AT-342 Image Figure 8. Global AT-342 Sales YoY Growth (2021-2032) & (W Units) Figure 9. HepaStem Image Figure 10. Global HepaStem Sales YoY Growth (2021-2032) & (W Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 13. Global Crigler-Najjar Syndrome Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Crigler-Najjar Syndrome Drug Market Share by Type 2025 VS 2032 Figure 15. North America Crigler-Najjar Syndrome Drug Sales Market Share in Volume by Type in 2025 Figure 16. North America Crigler-Najjar Syndrome Drug Sales Market Share in Value by Type in 2025 Figure 17. Europe Crigler-Najjar Syndrome Drug Sales Market Share in Volume by Type in 2025 Figure 18. Europe Crigler-Najjar Syndrome Drug Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Crigler-Najjar Syndrome Drug Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Crigler-Najjar Syndrome Drug Sales Market Share in Value by Type in 2025 Figure 21. Latin America Crigler-Najjar Syndrome Drug Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Crigler-Najjar Syndrome Drug Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Crigler-Najjar Syndrome Drug Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Crigler-Najjar Syndrome Drug Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Crigler-Najjar Syndrome Drug Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (W Units) Figure 29. Clinic Image Figure 30. Global Clinic Sales YoY Growth (2021-2032) & (W Units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 33. Global Crigler-Najjar Syndrome Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Crigler-Najjar Syndrome Drug Market Share by Application 2025 VS 2032 Figure 35. North America Crigler-Najjar Syndrome Drug Sales Market Share in Volume by Application in 2025 Figure 36. North America Crigler-Najjar Syndrome Drug Sales Market Share in Value by Application in 2025 Figure 37. Europe Crigler-Najjar Syndrome Drug Sales Market Share in Volume by Application in 2025 Figure 38. Europe Crigler-Najjar Syndrome Drug Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Crigler-Najjar Syndrome Drug Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Crigler-Najjar Syndrome Drug Sales Market Share in Value by Application in 2025 Figure 41. Latin America Crigler-Najjar Syndrome Drug Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Crigler-Najjar Syndrome Drug Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Crigler-Najjar Syndrome Drug Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Crigler-Najjar Syndrome Drug Sales Market Share in Value by Application in 2025 Figure 45. North America Crigler-Najjar Syndrome Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 46. North America Crigler-Najjar Syndrome Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Crigler-Najjar Syndrome Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Crigler-Najjar Syndrome Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Crigler-Najjar Syndrome Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 50. Europe Crigler-Najjar Syndrome Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Crigler-Najjar Syndrome Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Crigler-Najjar Syndrome Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Crigler-Najjar Syndrome Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 54. Asia-Pacific Crigler-Najjar Syndrome Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Crigler-Najjar Syndrome Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Crigler-Najjar Syndrome Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Crigler-Najjar Syndrome Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 58. Latin America Crigler-Najjar Syndrome Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Crigler-Najjar Syndrome Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Crigler-Najjar Syndrome Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Crigler-Najjar Syndrome Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 62. Middle East and Africa Crigler-Najjar Syndrome Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Crigler-Najjar Syndrome Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Crigler-Najjar Syndrome Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Crigler-Najjar Syndrome Drug Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Crigler-Najjar Syndrome Drug Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • ALXN-1540
  • AT-342
  • HepaStem
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Audentes Therapeutics Inc
  • Genethon SA
  • International Stem Cell Corp
  • Promethera Biosciences SA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Crigler-Najjar Syndrome Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Crigler-Najjar Syndrome Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Crigler-Najjar Syndrome Drug Market by Type
  6. 1.3.1 ALXN-1540
  7. 1.3.2 AT-342
  8. 1.3.3 HepaStem
  9. 1.3.4 Others
  10. 1.4 Global Crigler-Najjar Syndrome Drug Market Size by Type
  11. 1.4.1 Global Crigler-Najjar Syndrome Drug Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Crigler-Najjar Syndrome Drug Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Crigler-Najjar Syndrome Drug Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Crigler-Najjar Syndrome Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Crigler-Najjar Syndrome Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Crigler-Najjar Syndrome Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Crigler-Najjar Syndrome Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Crigler-Najjar Syndrome Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Crigler-Najjar Syndrome Drug Industry Trends
  2. 2.2 Crigler-Najjar Syndrome Drug Industry Drivers
  3. 2.3 Crigler-Najjar Syndrome Drug Industry Opportunities and Challenges
  4. 2.4 Crigler-Najjar Syndrome Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Crigler-Najjar Syndrome Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Crigler-Najjar Syndrome Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Crigler-Najjar Syndrome Drug Price (2021-2026)
  4. 3.4 Global Crigler-Najjar Syndrome Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Crigler-Najjar Syndrome Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Crigler-Najjar Syndrome Drug Company, Product Type & Application
  7. 3.7 Global Crigler-Najjar Syndrome Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Crigler-Najjar Syndrome Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Crigler-Najjar Syndrome Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Crigler-Najjar Syndrome Drug Tier 1, Tier 2, and Tier 3
4 Crigler-Najjar Syndrome Drug Regional Status and Outlook
  1. 4.1 Global Crigler-Najjar Syndrome Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Crigler-Najjar Syndrome Drug Historic Market Size by Region
  3. 4.2.1 Global Crigler-Najjar Syndrome Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Crigler-Najjar Syndrome Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Crigler-Najjar Syndrome Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Crigler-Najjar Syndrome Drug Forecasted Market Size by Region
  7. 4.3.1 Global Crigler-Najjar Syndrome Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Crigler-Najjar Syndrome Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Crigler-Najjar Syndrome Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Crigler-Najjar Syndrome Drug by Application
  1. 5.1 Crigler-Najjar Syndrome Drug Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Crigler-Najjar Syndrome Drug Market Size by Application
  6. 5.2.1 Global Crigler-Najjar Syndrome Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Crigler-Najjar Syndrome Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Crigler-Najjar Syndrome Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Crigler-Najjar Syndrome Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Crigler-Najjar Syndrome Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Crigler-Najjar Syndrome Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Crigler-Najjar Syndrome Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Crigler-Najjar Syndrome Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Audentes Therapeutics Inc
  2. 6.1.1 Audentes Therapeutics Inc Company Information
  3. 6.1.2 Audentes Therapeutics Inc Business Overview
  4. 6.1.3 Audentes Therapeutics Inc Crigler-Najjar Syndrome Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Audentes Therapeutics Inc Crigler-Najjar Syndrome Drug Product Portfolio
  6. 6.1.5 Audentes Therapeutics Inc Recent Developments
  7. 6.2 Genethon SA
  8. 6.2.1 Genethon SA Company Information
  9. 6.2.2 Genethon SA Business Overview
  10. 6.2.3 Genethon SA Crigler-Najjar Syndrome Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Genethon SA Crigler-Najjar Syndrome Drug Product Portfolio
  12. 6.2.5 Genethon SA Recent Developments
  13. 6.3 International Stem Cell Corp
  14. 6.3.1 International Stem Cell Corp Company Information
  15. 6.3.2 International Stem Cell Corp Business Overview
  16. 6.3.3 International Stem Cell Corp Crigler-Najjar Syndrome Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 International Stem Cell Corp Crigler-Najjar Syndrome Drug Product Portfolio
  18. 6.3.5 International Stem Cell Corp Recent Developments
  19. 6.4 Promethera Biosciences SA
  20. 6.4.1 Promethera Biosciences SA Company Information
  21. 6.4.2 Promethera Biosciences SA Business Overview
  22. 6.4.3 Promethera Biosciences SA Crigler-Najjar Syndrome Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Promethera Biosciences SA Crigler-Najjar Syndrome Drug Product Portfolio
  24. 6.4.5 Promethera Biosciences SA Recent Developments
7 North America by Country
  1. 7.1 North America Crigler-Najjar Syndrome Drug Sales by Country
  2. 7.1.1 North America Crigler-Najjar Syndrome Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Crigler-Najjar Syndrome Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Crigler-Najjar Syndrome Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Crigler-Najjar Syndrome Drug Market Size by Country
  6. 7.2.1 North America Crigler-Najjar Syndrome Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Crigler-Najjar Syndrome Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Crigler-Najjar Syndrome Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Crigler-Najjar Syndrome Drug Sales by Country
  2. 8.1.1 Europe Crigler-Najjar Syndrome Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Crigler-Najjar Syndrome Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Crigler-Najjar Syndrome Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Crigler-Najjar Syndrome Drug Market Size by Country
  6. 8.2.1 Europe Crigler-Najjar Syndrome Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Crigler-Najjar Syndrome Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Crigler-Najjar Syndrome Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Crigler-Najjar Syndrome Drug Sales by Country
  2. 9.1.1 Asia-Pacific Crigler-Najjar Syndrome Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Crigler-Najjar Syndrome Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Crigler-Najjar Syndrome Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Crigler-Najjar Syndrome Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Crigler-Najjar Syndrome Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Crigler-Najjar Syndrome Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Crigler-Najjar Syndrome Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Crigler-Najjar Syndrome Drug Sales by Country
  2. 10.1.1 South America Crigler-Najjar Syndrome Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Crigler-Najjar Syndrome Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Crigler-Najjar Syndrome Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Crigler-Najjar Syndrome Drug Market Size by Country
  6. 10.2.1 South America Crigler-Najjar Syndrome Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Crigler-Najjar Syndrome Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Crigler-Najjar Syndrome Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Crigler-Najjar Syndrome Drug Sales by Country
  2. 11.1.1 Middle East and Africa Crigler-Najjar Syndrome Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Crigler-Najjar Syndrome Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Crigler-Najjar Syndrome Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Crigler-Najjar Syndrome Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Crigler-Najjar Syndrome Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Crigler-Najjar Syndrome Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Crigler-Najjar Syndrome Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Crigler-Najjar Syndrome Drug Value Chain Analysis
  2. 12.1.1 Crigler-Najjar Syndrome Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Crigler-Najjar Syndrome Drug Production Mode & Process
  7. 12.2 Crigler-Najjar Syndrome Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Crigler-Najjar Syndrome Drug Distributors
  10. 12.2.3 Crigler-Najjar Syndrome Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst